Evidence map›Paper›PMID 33287237›Full record

ArticleBiomolecules2020

[

Ismaheel O Lawal, Gbenga O Popoola, Johncy Mahapane, Jens Kaufmann, Cindy Davis, Honest Ndlovu, Letjie C Maserumule, Kgomotso M G Mokoala, Hakim Bouterfa, Hans-Jürgen Wester and 2 more

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Advances in Radioligand Theranostics in Oncology.Molecular diagnosis & therapy · 2024
    Review
  6. Advances in PET Imaging of the CXCR4 Receptor: [Seminars in nuclear medicine · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Ismaheel O LawalDepartment of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.ORCID 0000-0003-4273-040X
Gbenga O PopoolaDepartment of Epidemiology and Community Health, University of Ilorin, Ilorin 240102, Nigeria.
Johncy MahapaneDepartment of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Jens KaufmannPentixaPharm GmbH, 97082 Wuerzburg, Germany.
Cindy DavisDepartment of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Honest NdlovuDepartment of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.
Letjie C MaserumuleDepartment of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.
Kgomotso M G MokoalaDepartment of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.
Hakim BouterfaPentixaPharm GmbH, 97082 Wuerzburg, Germany.
Hans-Jürgen WesterPharmazeutische Radiochemie, Technische Universität München, 85748 Garching, Germany.
Jan Rijn ZeevaartNuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.ORCID 0000-0003-0794-3012
Mike M SathekgeDepartment of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.ORCID 0000-0002-2806-0625
Steve Biko Hospital · ZASouth African Nuclear Energy Corporation (South Africa) · ZATechnical University of Munich · DEUniversity of Ilorin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People living with human immunodeficiency virus (PLHIV) have excess risk of atherosclerotic cardiovascular disease (ASCVD). Arterial inflammation is the hallmark of atherogenesis and its complications. In this study we aimed to perform a head-to-head comparison of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([

Indexed as

Fluorodeoxyglucose F18HIV InfectionsPositron Emission Tomography Computed TomographyReceptors, CXCR4AdultArteriesBiomarkersCoordination ComplexesFemaleGallium RadioisotopesHumansInflammationMaleMiddle AgedPeptides, CyclicPositron-Emission Tomography68Ga-pentixaforBiomarkersCoordination ComplexesCXCR4 protein, humanFluorodeoxyglucose F18Gallium RadioisotopesPeptides, CyclicRadiopharmaceuticalsReceptors, CXCR4[18F]FDG PET/CT[68Ga]Ga-pentixafor PET/CTarterial inflammationatherosclerotic cardiovascular diseasesHIV infection

Identifiers

PMID33287237
PMCPMC7761707
OpenAlexW3106781510

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.